Madeleine H. T. Ettaieb

Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study

Massimo Terzolo, Paola Perotti, Rossella Libé et al. · The Lancet Diabetes & Endocrinology · 2023 · 75 citations · Full text

Medicine, Oncology, Pharmacology +17

Adrenocortical carcinoma in children: First population-based clinicopathological study with long-term follow-up

Thomas Kerkhofs, Madeleine H. T. Ettaieb, Rob H.A. Verhoeven et al. · Oncology Reports · 2014 · 49 citations · Full text

Medicine, Endocrinology, Oncology +13

Synchronous vs. Metachronous Metastases in Adrenocortical Carcinoma: an Analysis of the Dutch Adrenal Network

Madeleine H. T. Ettaieb, J Düker, Richard A. Feelders et al. · Hormones and Cancer · 2016 · 19 citations · Full text

Medicine, Endocrinology, Oncology +16

Short-term variation in plasma mitotane levels confirms the importance of trough level monitoring

Thomas Kerkhofs, Luc J. J. Derijks, Madeleine H. T. Ettaieb et al. · European Journal of Endocrinology · 2014 · 16 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +10

Population Pharmacokinetic and Pharmacogenetic Analysis of Mitotane in Patients with Adrenocortical Carcinoma: Towards Individualized Dosing

Anyue Yin, Madeleine H. T. Ettaieb, Jesse J. Swen et al. · Clinical Pharmacokinetics · 2020 · 13 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17